Published in Gastroenterology Week, June 19th, 2006
According to recent research published in the journal Intensive Care Medicine, "Chylothorax is a rare but life-threatening condition in children. To date, there is no commonly accepted treatment protocol. Somatostatin and octreotide have recently been used for treating chylothorax in children. We set out to summarize the evidence on the efficacy and safety of somatostatin and octreotide in treating young children with chylothorax."
"A systematic literature search (Cochrane Library, EMBASE and PubMed databases) and literature hand search of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.